APTUS PHARMA LTD.● IPO DETAIL GMPNIL STATUSListed IPOCloudTrack Every IPO APTUS PHARMA LTD.● IPO DETAIL GMPNIL STATUSListed IPOCloudTrack Every IPO
Live GMP
Back to IPOs
Aptus Pharma Ltd.

Aptus Pharma Ltd.

BSE SME · SME IPO
Listed BSE SME SME Live Chart
Issue Price
₹70
₹70
GMP (Grey Market)
NIL
Unofficial data only
Est. Listing Price
₹70
Based on GMP
Min. Investment
₹140,000
1 lot × 2000 shares
Subscribed
1.00x
Over-subscribed
IPO Details
Open Date
23 Sep 2025
Close Date
25 Sep 2025
Allotment
26 Sep 2025
Listing Date
30 Sep 2025
Exchange
BSE SME
Price Band
₹70
Listing Price
See chart
Allotment Status
Price Band
₹70
Per share
Face Value
₹10 per share
 
Lot Size
2,000 Shares
per lot
Issue Size
18,60,000 shares (aggregating up to ₹13.02 Cr)
Total offering
Issue Type
Bookbuilding IPO
 
Min Investment
₹140,000
1 lot
Pre-IPO Holding
50,00,000 shares
Promoters
Post-IPO Holding
68,60,000 shares
Promoters
P/E (Pre)
11.29x
 
P/E (Post)
15.49x
 
EPS (Pre)
₹6.20
 
EPS (Post)
₹4.52
 
UPI Deadline
2025-09-25
Mandate
Anchor AllotmentMon, 22 Sep 2025
Basis of AllotmentFri, 26 Sep 2025
Refund InitiationMon, 29 Sep 2025
Demat CreditMon, 29 Sep 2025
Listing DayTue, 30 Sep 2025
UPI Mandate Deadline2025-09-25
Sale TypeFresh Capital
Net Offer to Public17,66,000 shares (aggregating up to ₹12.36 Cr)
Market Maker Quota94,000 shares (aggregating up to ₹0.6580 Cr)
QIB Quota50% of Net Issue
HNI / NII Quota15% of Net Issue
Retail Quota35% of Net Issue
Check AllotmentClick here →
Subscription Rate Final
Aptus Pharma Ltd. IPO subscribed 1.00 times overall. Retail: 1.00x. QIB: 1.00x. NII: 1.00x. By 25 Sep 2025.
QIB
1.00x
Over
NII/HNI
1.00x
Over
Retail
1.00x
Over
Total
1.00x
Over
Category Subscription Shares Offered % of Total Amount (₹Cr)
Market Maker
Awaited
94,000
₹0.66
QIB
Over 1.00x
NII / HNI
Over 1.00x
Retail
Over 1.00x
Total 1.00x
1,860,000
100% ₹13.02
IPO Shares Offered
Aptus Pharma Ltd. IPO total issue size: ₹13.02 Cr.
CategoryShares OfferedAmount (₹Cr)Size (%)
Market Maker 94,000 ₹0.66
5.05%
Total 1,860,000 ₹13.02
100.00%
* Based on upper price band ₹70 per share
Lot Size & Investment
Lot Size
2,000
Shares per Lot
Issue Price
₹70.00
Upper Band
Min Investment
₹140,000
1 Lot
ApplicationLotsSharesAmount
Retail (Min — 2 Lots)24,000₹280,000
Retail (Max — 13 Lots)1326,000₹1,820,000
S-HNI (Min — 14 Lots)1428,000₹1,960,000
B-HNI (Min — 68 Lots)68136,000₹9,520,000
* Issue Price ₹70 × Lot Size 2,000 shares
IPO Schedule
Anchor
22 Sep 2025
✓ Done
IPO Open
23 Sep 2025
✓ Done
IPO Close
25 Sep 2025
✓ Done
Allotment
26 Sep 2025
✓ Done
Refunds
29 Sep 2025
✓ Done
Demat Credit
29 Sep 2025
✓ Done
Listing Day
30 Sep 2025
✓ Done
Aptus Pharma Ltd. — Live Price LIVE
₹70.00
INR · BSE
Fetching…
vs Issue Price
OPEN
HIGH
LOW
MKT CAP
P/E
52W HIGH
52W LOW
VOLUME
DIVIDEND
DIV YIELD
Loading…
Chart Not Available
Try again 2–3 days after listing.
Issue ₹70.00 Live Price
About Aptus Pharma Ltd.
Incorporated in 2010, Aptus Pharma Ltd is engaged in the business of marketing, and distribution of finished pharmaceutical formulationsThe company manufactures and distributors of a broad range of pharmaceutical formulations covering multiple therapeutic areas: antacids & PPIs, pain management, anti-inflammatories, antibiotics, cardiology & antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, sachets, and more.Products:Aptus Pharma: Focuses on acute therapies i.e, anti-infectives, pain management, etc.Aptus CD care: Focused on chronic therapiesAptus Wellcare: Offers wellness and nutraceutical productsAptus Global: Export in overseas marketAs of March 31, 2025, the company has 194 pharmaceutical formulations in more than eleven therapeutic segments.Its warehouse is located over 15,732 sq. Feet and 1989 sq. feet in Ahmedabad, Gujarat. Its distribution model includes 125 direct and sub distributors and a sales team of 54 field personnel.As of March 31, 2025, the company had 70 employees.Competitive StrengthsDiversified product portfolioRobust distribution networkStrategic manufacturing alliances across Gujarat, Uttarakhand and Himachal PradeshCompetitive and cost-effective pricingExperienced management team
Objects of the Issue
1
Capital Expenditure for Office Premises with furniture and Industrial Racks
2
Working Capital
3
General corporate purposes
Aptus Pharma Ltd. Financials (Amount in ₹ Crore)
Revenue from Operations
₹13.9
31 Mar 2023
₹17.9
31 Mar 2024
₹24.6
31 Mar 2025
Profit After Tax (PAT)
₹0.2
31 Mar 2023
₹0.8
31 Mar 2024
₹3.1
31 Mar 2025
Particulars31 Mar 202531 Mar 202431 Mar 2023
Revenue from Operations 24.64 17.88 13.90
EBITDA 4.76 1.49 0.57
Profit After Tax (PAT) 3.10 0.80 0.19
Net Worth 6.97 1.77 0.97
Total Assets 21.92 10.03 6.22
Reserves & Surplus 1.97 1.47 0.67
Borrowings 10.36 5.31 2.21
EBITDA Margin (%) 19.31%
PAT Margin (%) N/A
RoE
44.50%
RoCE
45.66%
RoNW
44.50%
EBITDA Margin
19.31%
Debt/Equity
1.49
Issue Structure & Shareholding
Total Shares Offered18,60,000 (100.00%)
Net Offer to Public17,66,000 shares (aggregating up to ₹12.36 Cr)
Reserved for Market Maker94,000 shares (aggregating up to ₹0.6580 Cr)
Pre-Issue Promoter Holding50,00,000 shares
Post-Issue Promoter Holding68,60,000 shares
P/BV RatioN/A
RoE44.50%
RoCE45.66%
Debt / Equity1.49
Script CodeN/A
Registrar & Lead Managers
Book Running Lead Managers
Interactive Financial Services Ltd
GMP Disclaimer: Grey Market Premium data is unofficial and unregulated. It does not guarantee actual listing price.
IPO Subscription FAQs
How much Aptus Pharma Ltd. IPO subscribed?

Aptus Pharma Ltd. IPO is subscribed 1.00 times by Sep 25, 2025. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.

Investor CategorySubscription
Qualified Institutional (QIB)1.00x
Non Institutional (NII/HNI)1.00x
Retail Individual1.00x
Total Subscription1.00x
What is Aptus Pharma Ltd. IPO retail subscription status?

The Aptus Pharma Ltd. IPO retail category is subscribed 1.00 times as of 25 Sep 2025. The retail portion is oversubscribed.

How to subscribe Aptus Pharma Ltd. IPO?

Subscribe via your broker app using ASBA or UPI. Opens 23 Sep 2025 and closes 25 Sep 2025. Min investment: ₹140,000 (1 lot = 2,000 shares). UPI mandate: 2025-09-25.

How many times Aptus Pharma Ltd. IPO subscribed?

The Aptus Pharma Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.

How to check Aptus Pharma Ltd. IPO allotment?

Check allotment on the registrar website (Bigshare Services Pvt.Ltd.) at https://ipo.bigshareonline.com/IPO_Status.html. Enter your PAN, application number or DP/Client ID. Allotment date: 26 Sep 2025. Refunds: on 29 Sep 2025.

When Aptus Pharma Ltd. IPO will be listed?

The Aptus Pharma Ltd. IPO listing date is 30 Sep 2025, Tuesday. Listed on: BSE SME. Issue price: ₹70. Estimated listing: ₹70. GMP: NIL.

When Aptus Pharma Ltd. IPO close?

The Aptus Pharma Ltd. IPO closes on 25 Sep 2025, Thursday. UPI mandate: 2025-09-25. Allotment: 26 Sep 2025. Listing: 30 Sep 2025.